Luteinizing hormone-releasing hormone fragment 4, associated with the CAS number 51776-33-1, is a peptide that plays a crucial role in the regulation of reproductive hormones. This fragment is derived from the larger luteinizing hormone-releasing hormone (LHRH) and is involved in stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland. Characteristically, this peptide is typically composed of a specific sequence of amino acids that contribute to its biological activity. It is often utilized in research and clinical settings to study reproductive functions and hormonal regulation. The stability, solubility, and bioactivity of this peptide can vary depending on its formulation and the conditions under which it is stored or administered. Additionally, it may have implications in therapeutic applications, particularly in the context of fertility treatments or hormone-related disorders. As with many peptides, its synthesis can be achieved through solid-phase peptide synthesis or recombinant DNA technology, allowing for precise control over its structure and purity.

luteinizing hormone releasing hormone*fragment 4-

51776-33-1: Luteinizing hormone-releasing hormone fragment 4, associated with the CAS number 51776-33-1, is a peptide that plays a crucial role in the regulation of reproductive hormones. This fragment is derived from the larger luteinizing hormone-releasing hormone (LHRH) and is involved in stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior pituitary gland. Characteristically, this peptide is typically composed of a specific sequence of amino acids that contribute to its biological activity. It is often utilized in research and clinical settings to study reproductive functions and hormonal regulation. The stability, solubility, and bioactivity of this peptide can vary depending on its formulation and the conditions under which it is stored or administered. Additionally, it may have implications in therapeutic applications, particularly in the context of fertility treatments or hormone-related disorders. As with many peptides, its synthesis can be achieved through solid-phase peptide synthesis or recombinant DNA technology, allowing for precise control over its structure and purity.

LH-RH (4-10), a heptapeptide from LHRH degradation, is made in macrophages and type II pneumocytes.

LH-RH (4-10)

<p>Please enquire for more information about LHRH (4-10) acetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

CAS 51776-33-1

luteinizing hormone releasing hormone*fragment 4-

LH-RH (4-10)

Ref: TM-T76354

LHRH (4-10) acetate salt

Ref: 3D-FL109077